Identification and Expression Analysis of Spastin Gene Mutations in Hereditary Spastic Paraplegia
- 作者Ingrid K. Svenson; Allison E. Ashley-Koch; P. Craig Gaskell; Travis J. Riney; W. J. Ken Cumming; Helen M. Kingston; Edward L. Hogan; Rose-Mary N. Boustany; Jeffery M. Vance; Martha A. Nance; Margaret A. Pericak-Vance; Douglas A. Marchuk
- 卷第68卷
- 期第5期
- 印刷ISSN0002-9297
- 电子ISSN1537-6605
- 文件大小756.89KB
- 发表时间2001
- DOI10.1086/320111
Toxicity equivalence range design (TEQR): A practical Phase I designM. Suzette Blanchard; Jeffrey A. Longmate · 2011
Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosisMerry L. Tetef; Kim A. Margolin; James H. Doroshow; Steven Akman; Lucille A. Leong; Robert J. Morgan Jr.; James W. Raschko; Neil Slatkin; George Somlo; Jeffrey A. Longmate; Mary I. Carroll; Edward M. Newman · 2000
Spontaneous mutation in Big Blue® mice from fetus to old age: Tissue-specific time courses of mutation frequency but similar mutation typesKathleen A. Hill; Victoria L. Buettner; Asanga Halangoda; Makoto Kunishige; Stephen R. Moore; Jeffrey Longmate; William A. Scaringe; Steve S. Sommer · 2004
Mamu-A⁎01/Kb transgenic and MHC Class I knockout mice as a tool for HIV vaccine developmentJinliang Li; Tumul Srivastava; Ravindra Rawal; Edwin Manuel; Donna Isbell; Walter Tsark; Corinna La Rosa; Zhongde Wang; Zhongqi Li; Peter A. Barry; Katharine D. Hagen; Jeffrey Longmate; Don J. Diamond · 2009
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96Warren A. Chow; Timothy W. Synold; Merry L. Tetef; Jeffrey Longmate; Paul Frankel; Joyce Lawrence; Zaid Al-Khadimi; Lucille Leong; Dean Lim; Kim Margolin; Robert J. Morgan; James Raschko; Stephen Shibata; George Somlo; Przemyslaw Twardowski; Yun Yen; James H. Doroshow · 2004
Tissue-specific time courses of spontaneous mutation frequency and deviations in mutation pattern are observed in middle to late adulthood in Big Blue miceKathleen A. Hill; Asanga Halangoda; Petra W. Heinmoeller; Kelly Gonzalez; Chaniga Chitaphan; Jeffrey Longmate; William A. Scaringe; Ji-Cheng Wang; Steve S. Sommer · 2005
First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignanciesGlen J. Weiss, Joseph Chao, Jeffrey D. Neidhart, Ramesh K. Ramanathan, Dawn Bassett, James A. Neidhart, Chung Hang J. Choi, Warren Chow, Vincent Chung, Stephen J. Forman, Edward Garmey, Jungyeon Hwang, D. Lynn Kalinoski, Marianna Koczywas, Jeffrey Longmate, Roger J. Melton, Robert Morgan, Jamie Oliver, Joanna J. Peterkin, John L. Ryan, Thomas Schluep, Timothy W. Synold, Przemyslaw Twardowski, Mark E. Davis, Yun Yen…show all 25hide · 2013